newsfilter
← Latest News
GlobeNewswire·

Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan

CAMBRIDGE, Mass., March 31, 2023 (GLOBE NEWSWIRE) -- Magenta Therapeutics, Inc. (NASDAQ:MGTA) ("Magenta" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited